Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine
Sign Up to like & getrecommendations! Published in 2023 at "Neurology International"
DOI: 10.3390/neurolint15010017
Abstract: Background: The aim of the present study was to assess the migraine outcome, in particular migraine disability, in chronic (CM) and high frequency episodic migraine (HFEM) patients in treatment with galcanezumab. Methods: The present study… read more here.
Keywords: disability; migraine; treatment galcanezumab; chronic high ... See more keywords